Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to prevent language delays in kids of parents with addiction

NCT ID NCT07529327

Prevention Sponsor: University of Oregon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding extra supports—like telehealth coaching and practical help—to a group parenting program can prevent language delays in young children (12-42 months) of parents with substance use disorders. 244 parents will be assigned to the group program alone or with added enhancements. The goal is to improve how parents respond to their child's communication and boost the child's vocabulary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (parenting groups, coaching, and practical support)
What this could lead to
If successful, this could point toward a simple, scalable way to prevent language delays in children at risk due to parental substance use.
What could go wrong
This is a relatively small, early-stage trial. The extra supports may not improve language outcomes more than the group intervention alone, and results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 244 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Nov 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Have a: 1. Self-reported lifetime history of substance use disorder treatment and/or 2. active substance use in the past year 2. Be providing care for/parenting a child at least 10% of the time who is: 1. between the ages of 12-42 months 2. English/Spanish bilingual or monolingual in English or Spanish 3. exposed to a third language once a week or less 4. not yet combining three or more words regularly 5. has less than 150 words in their expressive vocabulary 3. Be able to provide consent for their target child to participate, or have a legal guardian provide consent for the child to participate 4. Be able to speak and understand English and/or Spanish 5. Be willing to attend groups once a week for six weeks at a participating site/group time 6. If assigned additional services, willing to attend Zoom meetings 7. Be 18 years of age or older Exclusion Criteria: -Only one caregiver per focal child can participate in the research study. Caregivers whose participating child already has another caregiver enrolled in the research study will not be eligible to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Language delay are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Language Development Disorders substance-related disorder language disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Language delay Language development Language disorders in children Prevention intervention Substance use disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Prevention Science Institute

    RECRUITING

    Eugene, Oregon, 97403, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.